Articular cartilage in osteoarthritic patients: efectos of diclofenac, celecoxib and glucosamine sulfate on inflammatory markers

Osteoarthritis is a chronic and progressive joint disease. It is established by a complex process involving mechanical and  biological alterations of the musculoskeletal system, which are generated by a great variety of interactions between  enetic  factors and extrinsic i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brizuela, Nilda Y, Montrull, Hilda L, Demurtas , Silvia L, Meirovich, Carlos I
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2019
Materias:
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/25897
Aporte de:
Descripción
Sumario:Osteoarthritis is a chronic and progressive joint disease. It is established by a complex process involving mechanical and  biological alterations of the musculoskeletal system, which are generated by a great variety of interactions between  enetic  factors and extrinsic injuries. The pathogenesis of this disease is related to an increased and clivergent production of infiammatory markers and proteolytic enzymes that promote the degradation and destruction of the extracellular matrix of  articular and periarticular tissues. Cartilage samples were taken frorn 20 osteoarthritic patients during programmed surgical interventions. The cartilage samples were cultu red in Dulbecco-Eagle medium. With or without the addition of  SAIDs or modulators of chondrocyte metabolism. The content of nitric oxide in the supernatant was quantified using the  Griess reaction: the concentration of MMP- 1 was quantificd vía double-sandwich ELISA. Untreated chondrocyte cultures  produced 1950 ± 665ng/ml MMP-1. Wíth the addition of Diclofenac this value decreased to 1140 ± 155 ng/mi, although  his difference was not statistically significant (p<0 ,06). However, in the presence of Celecoxib the level significantly dropped to 760 ± 75 ng/mI (p<0,01). Although the addition of glucosarnine did not produce such a noticeable reduction in  The level of MMP- 1 (950±89 ng/mi), it was statistically significant (p<0,05). On the contraly, none of the drugs (Diclofenac, Celecoxib, Glucosamine) modified the level of nitric oxide which had a mean value of 47,3 ± 4.911M in the  Control samples. This investigation evidenced the inability of Diclofenac to significantly modifr the production of  proteolytic enzymes in osteoarthritic chondrocyte cultures. However, both Celecoxib and Glucosamine significantly  reduced the production of MMP- 1. On the contrary, none of the drugs used in this study managed to modify the  concentration of nitric oxide. To the present day, no drugs have been found to be efficient in altering the natural course of  the disease, requiring further investigation